| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
241,350.72 | 161,004.31 | 147,479.98 | 183,725.82 | 97,019.88 |
| Cost of Revenue
|
-151,206.37 | -114,796.63 | -97,080.89 | -110,354.03 | -64,381.19 |
|
Gross Profit
|
90,144.35 | 46,207.67 | 50,399.10 | 73,371.80 | 32,638.69 |
| Selling, General and Administrative Expenses
|
-4,484.56 | -4,615.37 | -4,894.07 | -4,934.47 | -1,773.59 |
| Other Income/Expense, Operating
|
-1,849.59 | -1,689 | 227.56 | -1,606.44 | -1,045.64 |
|
Operating Income/Expenses
|
-6,334.15 | -6,304.37 | -4,666.51 | -6,540.91 | -2,819.23 |
|
Total Operating Profit/Loss
|
83,810.20 | 39,903.30 | 45,732.59 | 66,830.89 | 29,819.46 |
| Total Net Finance Income/Expense
|
5,250.10 | 4,934.40 | 7,907.20 | 4,011.85 | -320.09 |
| Net Investment Income
|
-352.69 | 5,140.54 | -1,892.31 | 1,104.51 | 11.55 |
| Irregular Income/Expenses
|
0 | 0 | -1,589.70 | -813.25 | 0 |
|
Non-Operating Income/Expenses, Total
|
4,897.41 | 10,074.95 | 4,425.19 | 4,303.12 | -308.53 |
|
Pretax Income
|
88,707.61 | 49,978.25 | 50,157.77 | 71,134 | 29,510.93 |
|
Net Income from Continuing Operations
|
88,707.61 | 49,978.25 | 50,157.77 | 71,134 | 29,510.93 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
88,707.61 | 49,978.25 | 50,157.77 | 71,134 | 29,510.93 |
|
Net Income after Non-Controlling/Minority Interests
|
88,707.61 | 49,978.25 | 50,157.77 | 71,134 | 29,510.93 |
| Preferred/Other Stock Distribution
|
-1,740.98 | -1,740.98 | -1,740.98 | -8,638.04 | -4,684.66 |
|
Other Adjustments to Net Income Available to Common Stockholders
|
-1,675.77 | -1,675.77 | -2,311.17 | -2,508.40 | -61.91 |
|
Net Income Available to Common Stockholders
|
85,290.86 | 46,561.49 | 46,105.62 | 59,987.56 | 24,764.36 |
|
Diluted Net Income Available to Common Stockholders
|
85,290.86 | 46,561.49 | 46,105.62 | 59,987.56 | 24,764.36 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
83,457.52 | 45,043.85 | 42,250.58 | 67,122.15 | 29,831.01 |
|
EBITDA
|
114,764.45 | 70,974.40 | 59,242.48 | 82,751.27 | 42,121.48 |
|
Normalized EBITDA
|
117,492.54 | 74,162.05 | 64,229.26 | 85,999.37 | 42,238.73 |
|
Normalized Income
|
90,548.27 | 49,638.40 | 55,144.56 | 74,382.10 | 29,628.18 |
|
Total Unusual Items
|
3,377.86 | 2,219.90 | 6,970.59 | 2,822.06 | 117.26 |
|
Total Unusual Items Excluding Goodwill
|
3,377.86 | 2,219.90 | 6,970.59 | 2,822.06 | 117.26 |
|
Tax Effect of Unusual Items
|
1,351.14 | 887.96 | 2,788.24 | 1,128.82 | 46.90 |
|
Tax Rate, Calculated
|
0.40 | 0.40 | 0.40 | 0.40 | 0.40 |
12/31/2022 - 12/6/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade